Venture Shape builds investor websites, decks and scientific visuals for biotech companies, including immersive, interactive scientific experiences on the web. This guide is for the PR, communications and IR firms that write the messages this work carries.
Partner opportunities 01 / 15
Your side of the table
More capacity. Broader capabilities. Higher-quality execution.
01
Capacity
Readouts, raises, R&D Days and JPM in January stack up. Get reliable execution support when client deadlines collide.
02
Capabilities
Expand what you can offer clients with specialized biotech websites, investor decks, scientific visuals and interactive experiences.
03
Quality
Deliver high-quality, investor-facing materials with the benefit of senior-level judgment, scientific understanding and hands-on execution.
Partner opportunities 02 / 15
Where this fits
Where Venture Shape fits at Ascent.
Ascent leads
Strategic communications planning
Brand messaging and positioning
Public relations and media engagement
Content strategy and development
Executive communications
Venture Shape builds
Investor decks and presentation systems
Investor-facing websites
Scientific and mechanism visuals
Interactive web animation
Partner opportunities 03 / 15
What you can hand off
One narrative. All surfaces.
01
Investor-Facing Websites
Custom websites presenting the science, pipeline and team through clear content, design and CMS implementation.
02
Investor Presentation Systems
Master investor narratives, presentation variants and scientific figure systems built from one communication hierarchy.
03
Scientific Visual Experiences
Static and interactive scientific visuals that make complex mechanisms, platforms, programs and pipelines easier to understand.
Works with the system you use.
Venture Shape can build within your existing CMS or recommend the right platform for the project.
Ready when the moment is.
Venture Shape can accommodate accelerated schedules and coordinate launches around key events.
Partner opportunities 04 / 15
Section 04
Five pieces, five different problems.
Each piece started from a communication problem, and the format came out of that problem. Every one is live at ventureshape.com/work.
Ostium Bio
Aperiod Therapeutics
Cytovara Therapeutics
Halden Bio
Nexora
Partner opportunities 05 / 15
Scroll-driven story
Ostium Bio
The story explains a half-life problem and the chemistry that fixes it without an equation.
The story opens on its claim that the clock is the problem. Then it lets the reader watch the gut's two-minute signal before the molecule appears.
ventureshape.com/embed/ostium
Partner opportunities 06 / 15
Scroll-driven story
Aperiod Therapeutics
The story turns a once-weekly dosing profile into something an investor can feel.
The reader moves from the sawtooth of today's dosing to the gut's own clock, then to the device, then to the curve the company is after.
ventureshape.com/embed/tempo
Partner opportunities 07 / 15
Tumor burden 99%
The T cells engage
Stalled at 82%
Interactive comparison
Cytovara Therapeutics
The piece makes an adaptive CAR-T platform legible to a generalist investor.
The reader runs each therapy on the same tumor and watches what changes. The platform's claim becomes something they test for themselves.
ventureshape.com/showcase/cytovara
Partner opportunities 08 / 15
Scroll-driven story
Halden Bio
The piece shows what a steady dose does to the curve, and why the patch is the point.
The patch delivers the same weekly milligrams, spread thin. The reader watches the trough fill in as the peaks disappear.
ventureshape.com/embed/halden
Partner opportunities 09 / 15
Investor website
Nexora
The site states the instrument, the workflow and the applications in one pass.
This is a full website in the company's own visual identity. It draws the microfluidic workflow as a flow the reader can follow from sample to result.
ventureshape.com/showcase/nexora
Partner opportunities 10 / 15
Engagement
Three ways to bring me in.
1
Under your name
I work behind the scenes as part of your team, with you managing the client relationship.
2
As your named specialist
You introduce me as the specialist on the build, and you stay the lead.
3
By introduction
The client contracts with me for the build, and you keep the strategy.
You choose for each client.
Partner opportunities 11 / 15
Who you WILL work with
Senior ownership. From narrative through execution.
Founder Matt Dennis combines biotech agency ownership with design, scientific visualization, animation and programming. The person shaping the narrative also produces the work.
Matt Dennis / Founder
Background
Built and ran a 12-person agency. I know what a subcontractor owes the firm that hired it.
15+ years across biotech communication, design and full-stack development.
Primary architect of a 400+ site enterprise platform for the U.S. Department of Veterans Affairs.
I built AI systems for research, design, build and QA work. I direct agents and make the final calls.
Partner opportunities 12 / 15
Trust
Confidential by default, and calendar-aware by habit.
We sign an NDA and a non-solicit before the first file moves.
Material for an announcement stays staged and private until release.
I work around quiet periods, embargoes and the IR calendar you already run.
Partner opportunities 13 / 15
FAQ
Questions partners ask.
Do I have to explain the science?
No. Send the papers and posters. I read them and come back with questions.
Can you work in the client's CMS?
Yes, or I recommend one when the client needs it.
How fast can you move?
I move fast when a launch is tied to an event, and I hold the dates you book.
How do you price the work?
I scope each job after a call and give you a fixed quote you can mark up.
Who does the work?
I do, with AI systems I built for research, production and QA.
Partner opportunities 14 / 15
Next step
Bring me the part of the story that's hardest to show.
One brief is enough to start. You can see the work at ventureshape.com/work.
Matt Dennis matt@ventureshape.com 910-599-6483 (cell)
